Amedei, A.

Coffelt, S.B.

Granot, Z.

Muthana, M.

Rahat, M.A.

Mediators of Inflammation

PubMed

Rahat, Michal A.

Coffelt, Seth

Granot, Zvi

Muthana, Munitta

Amedei, Amedeo

Enlighten: Publications

Macrophages and neutrophils: regulation of the inflammatory microenvironment in autoimmunity and cancer

White Rose Research Online

Macrophages and Neutrophils: Regulation of the Inflammatory Microenvironment in Autoimmunity and Cancer.

Enlighten

English

Michal A. Rahat

Seth B. Coffelt

Zvi Granot

Munitta Muthana

Amedeo Amedei

Directory of Open Access Journals

Macrophages and Neutrophils: Regulation of the Inflammatory Microenvironment in Autoimmunity and Cancer

Crossref

EditorialMacrophages and Neutrophils: Regulation of the InflammatoryMicroenvironment in Autoimmunity and CancerMichal A. Rahat,1 Seth B. Coffelt,2 Zvi Granot,3 Munitta Muthana,4 and Amedeo Amedei51Carmel Medical Center and The Ruth and Bruce Rappaport Faculty of Medicine, Technion, 3436212 Haifa, Israel2CRUK Beatson Institute, Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1BD, UK3Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada,The Hebrew University-Hadassah Medical School, 91120 Jerusalem, Israel4Academic Unit of Inflammation & Tumor Targeting, Department of Oncology & Metabolism, The Medical School,University of Sheffield, Sheffield S10 2RX, UK5Department of Experimental and Clinical Medicine, University of Florence, 350134 Florence, ItalyCorrespondence should be addressed to Michal A. Rahat; mrahat@netvision.net.ilReceived 3 May 2016; Accepted 4 May 2016Copyright © 2016 Michal A. Rahat et al.This is an open access article distributed under theCreativeCommonsAttribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Macrophages and neutrophils are phagocytes that play majorroles in the onset and maintenance of many diseases. Thesetwo cell types that belong to the innate immune system areextremely plastic and can move between different modes ofactivation upon cues received from their immediatemicroen-vironment [1–3]. Once activated, these cells secrete myriad ofmediators that shape and regulate the microenvironment, aswell as other immune cells, such that this continuous dialoguedetermines the direction of the immune response and itsoutcome [4]. This is highlighted in this issue as we focuson the role of macrophages and neutrophils in both cancerand autoimmune diseases. Although these are different dis-eases, with opposing pathophysiologies and activation of theimmune system, some similarities do exist [5]. By comparingthese two cell populations in cancer and autoimmune dis-eases, in the context of their respective microenvironment,we try to examine whether there are similar attributes thatcould potentially be exploited as new therapeutic strategies.Most of the manuscripts in this issue are dedicated tocancer and the tumor microenvironment (TME), reflectingthe abundance of information on macrophages, and thenow growing recognition of the role that neutrophils playin the cancerous context. In contrast, the role that bothmacrophage and neutrophils play in autoimmune diseases isonly beginning to emerge and merits more investigation.We begin with the remote microenvironment. As theTME can remotely affect circulating blood cells, O. Balacescuet al. performed transcriptional analysis in blood samplesderived from triple negative (HER2-ve) breast cancer patients(TNBC).These studies revealed distinctmolecular signaturesaccording to estrogen and progesterone receptor (ER and PR)status. They found significant enrichment of altered systemicimmune-related pathways in the blood of TNBC patientsand this correlated with an increase in inflammation andnecrosis in primary tumors. The authors also propose thatimmunotherapy could possibly be synergistic to chemother-apy to improve the clinical outcome of these patients.In a series of papers, the role of macrophages in cancer isaddressed, as well as their potential to become targets or vehi-cles of therapy. C. Eyileten et al. highlight the role of immunecells and the cellular factors they produce, in promoting orpreventing cancer development. They describe how thesecells, which include tumor-associated macrophages (TAMs),dendritic cells, neutrophils, T cells, and NK cells, can betargeted or exploited to induce antitumor immunity anddiscuss the pioneering studies where these cells have beenmanipulated to exhibit antitumor activity.The ability of TAMs to produce IL-6 and activate STAT3has been associatedwith chemoresistance andpoor prognosisin several cancers including colorectal carcinoma. How-ever, it remains unclear whether anticytokine therapy couldreverse this, help regain chemosensitivity, and enhance thesuppressive effect of chemotherapy on tumor growth. Z.-Y. Wang et al. demonstrate that treatment of carboplatinHindawi Publishing CorporationMediators of InﬂammationVolume 2016, Article ID 5894347, 3 pageshttp://dx.doi.org/10.1155/2016/58943472 Mediators of Inflammationincreased IL-6 production and STAT3 activation in a dose-dependent manner in the human colorectal LoVo cells,whereas anti-IL-6 neutralizing antibody enhanced theirchemosensitivity to carboplatin, abolished STAT3 activation,and increased cell apoptosis. These results suggest a new wayto increase the efficacy of chemotherapy.Nonresolving inflammation is one of the consistent fea-tures of the tumor microenvironment and in the intestine;this plays a critical role in the initiation and develop-ment of colon cancer. In the study by Y. Wang et al., theinhibitory effect of a novel soy-protein-derived isoflavonoidon inflammation-related colon cancer cell proliferation isdescribed. The anticancer role of a newly synthesized deriva-tive of genistein, GEN-27, was shown to have both antiprolif-erative and anti-inflammatory properties in colon cancer cellsand monocytic cells via modulation of the NF-𝜅B pathway.N. J. Brady et al. discuss macrophages in the con-text of normal mammary gland development and mam-mary tumorigenesis. The review highlights the vital role ofmacrophages in mammary gland generation and homeosta-sis, as well as their contribution to tumor formation andprogression.B. Sainz Jr. et al. review the current literature on cancerstem cells and macrophages. This article focuses on themolecular crosstalk between the two cell types within thepremalignant niche and established tumors, which influencescancer progression.We then proceed with the introduction of neutrophilsand their function in cancer, as well as their interactionswith macrophages. Z. Granot and J. Jablonska review thepro- and antitumor properties neutrophils exhibit, which areregulated by cues in the tumor microenvironment. Muchlike macrophages, neutrophils are not a homogeneous pop-ulation of cells and can become either protumoral (N1) orantitumoral (N2). Moreover, neutrophils have a major role ingenerating the premetastatic niche, as indicated by the largenumber of neutrophils accumulated in such sites. However,whether neutrophils are activated as N1 or N2 is dictatedby the TME. Much remains unknown about the possibleactivationmodes of neutrophils, their biologicalmarkers, andtheir functions in the polarized state in the tumoral context.M. Orozco-Morales et al. review the interplay betweenmolecular inflammatory mediators and the immune cellsrecruited to Non-Small Cell Lung Cancer (NSCLC). Theyhighlight the roles played by various factors in regulatingthe function of TAMs and Tumor-Associated Neutrophils(TANs) in the context ofNSCLC. Finally, they discuss the roleof tumor cell expressed CD47 in mediating immune evasion.The inflammatory microenvironment, as studied espe-cially in tumors but also in inflammatory diseases such asrheumatoid arthritis (RA), is very hypoxic, and the lackof available oxygen influences both macrophages and neu-trophils, as discussed by A. Egners et al.. Hypoxia inducesor activates major transcription factors, such as hypoxiainducible factors (HIFs) 1 and 2 and NF-𝜅B, and thosein turn mediate and regulate the hypoxic stress. This ismanifested by major changes in every aspect of macrophageand neutrophil functions, including their migration andadhesion to endothelial cells, their ability to kill bacteria, theirmetabolism and polarization, production of cytokines, andprotumorigenic activity, as reviewed in this paper.The tumor microenvironment (TME) polarizes TAMsand TANs to become protumoral and support tumor growthand progression, invasiveness and metastasis, angiogenesis,and matrix remodeling, while inhibiting the antitumoralimmune surveillance. In inflammatory microenvironmentsand in TME, neutrophils can recruit macrophages, andthese, in turn, affect neutrophil functions, thereby exhibitingdifferent degrees of interaction between these two cell types.KimandBae explore the biology of TAMs andTANs and theirrecruitment and polarization and discuss their possible inter-actions in the TME as well as their role in TME maintenanceand their significance in clinical settings. They concludedthat the introduction of more sophisticated tumor modelsand techniques to differentiate different myeloid cell subsetsin vivo will reveal fundamental information about possiblemodulation of myeloid cells, including their interaction withplatelets in each progression stage of different cancer types.To finalize the issue, we address the role of macrophagesand neutrophils in autoimmune diseases. The involvementof macrophages in autoimmune disease of the brain ishighlighted in a review by X. Fan et al. Although currentknowledge is quite limited, the ability of macrophages topolarize in different activation modes and carry out differentand often opposing tasks renders them important media-tors of the pathogenesis of diseases such as neuromyelitisoptica (NMO), myasthenia gravis (MG), and Guillain-Barre´syndrome (GBS), and burning questions, such as whethermacrophages can be targeted or used as future therapeuticagents, must be further explored.Concluding this special issue is a detailed review by M.A. Rahat and J. Shakya that draws parallels between thecancerous and autoimmune microenvironments. From thepoint of view of the immune response, cancer and autoim-mune diseases, where the immune system is suppressedor hyperactivated, respectively, are opposites. Nonetheless,many elements in the microenvironments are common inboth diseases including hypoxia, angiogenesis, the presenceof autoantibodies, and cytokine concentrations. Of course,the critical role that myeloid cells, macrophages, and neu-trophils in particular play in these diseases and the detailedunderstanding of the similarities and differences in thetwo contexts may eventually lead to novel approaches toimmunotherapies.Collectively, these papers highlight the critical impor-tance of macrophages and neutrophils in the microenviron-ments of both cancerous and autoimmune diseases. Thesecells can sense the changing microenvironment and interpretthe signals and via complex interactions with other tissuecells and infiltrating immune cells, including the interactionsbetweenmacrophages andneutrophils themselves, they regu-late the progression of the immune response in these diseases[6]. These different interactions could become a focus ofresearch in the field in the coming years. Moreover, althoughthe role that macrophages play in the cancer microenvi-ronment has been extensively studied in the last decade,still some areas deserve more attention, for example, thecrosstalk between different microenvironmental factors suchMediators of Inflammation 3as hormones and hypoxia. Neutrophils bearmany similaritiesto macrophages, in their secretome and their killing andproangiogenic abilities and in the way the microenvironmentactivates them in different and opposing manners. However,this has only recently begun to be unveiled, andmore researchdirected at neutrophil characterization, understanding oftheir contribution, and deciphering their interactions withdifferent cell populations must be invested. And lastly, thecurrent knowledge and the findings described in this issuepoint to several new insights into the mechanisms of currentand potential therapies and suggest new possible combi-nation therapies that could benefit patients and should befurther explored.Michal A. RahatSeth B. CoffeltZvi GranotMunitta MuthanaAmedeo AmedeiReferences[1] Z. G. Fridlender, J. Sun, S. Kim et al., “Polarization of tumor-associated neutrophil phenotype by TGF-𝛽: ‘N1’ versus ‘N2’TAN,” Cancer Cell, vol. 16, no. 3, pp. 183–194, 2009.[2] A. Mantovani, G. Germano, F. Marchesi, M. Locatelli, and S.K. Biswas, “Cancer-promoting tumor-associated macrophages:new vistas and open questions,” European Journal of Immunol-ogy, vol. 41, no. 9, pp. 2522–2525, 2011.[3] A. Mantovani, S. K. Biswas, M. R. Galdiero, A. Sica, and M.Locati, “Macrophage plasticity and polarization in tissue repairand remodelling,” Journal of Pathology, vol. 229, no. 2, pp. 176–185, 2013.[4] M. R. Galdiero, C. Garlanda, S. Jaillon, G. Marone, and A.Mantovani, “Tumor associatedmacrophages and neutrophils intumor progression,” Journal of Cellular Physiology, vol. 228, no.7, pp. 1404–1412, 2013.[5] R. Kim, M. Emi, and K. Tanabe, “Cancer immunosuppres-sion and autoimmune disease: beyond immunosuppressivenetworks for tumour immunity,” Immunology, vol. 119, no. 2, pp.254–264, 2006.[6] C. Stockmann, D. Schadendorf, R. Klose, and I. Helfrich, “Theimpact of the immune system on tumor: angiogenesis andvascular remodeling,” Frontiers in Oncology, vol. 4, article 69,2014.Submit your manuscripts athttp://www.hindawi.comStem CellsInternationalHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014MEDIATORSINFLAMMATIONofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Behavioural NeurologyEndocrinologyInternational Journal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Disease MarkersHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014BioMed Research InternationalOncologyJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Oxidative Medicine and Cellular LongevityHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014PPAR ResearchThe Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Journal ofObesityJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014 Computational and  Mathematical Methods in MedicineOphthalmologyJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Diabetes ResearchJournal ofHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Research and TreatmentAIDSHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Gastroenterology Research and PracticeHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014Parkinson’s DiseaseEvidence-Based Complementary and Alternative MedicineVolume 2014Hindawi Publishing Corporationhttp://www.hindawi.com

Macrophages and Neutrophils: Regulation of the Inflammatory Microenvironment in Autoimmunity and Cancer.

Abstract

Similar works

Full text

Available Versions

Enlighten: Publications

White Rose Research Online

Enlighten

Directory of Open Access Journals

White Rose Research Online

Crossref